Chalcone Derived from a Natural Product: An Integrated Approach of Quantum Chemical Calculations, Molecular Docking, ADME and Neuromodulation on Serotonergic Receptors in Adult Zebrafish
DOI:
https://doi.org/10.29169/1927-5951.2025.15.07Keywords:
Chalcones, Anxiolytic effect, Serotonergic receptors, ZebrafishAbstract
Anxiety disorders are conditions characterized by heightened responses to perceived threats, resulting in symptoms that negatively affect everyday life. This study investigates the anxiolytic effect of a natural chalcone isolated from Croton anisodontus Müll.Arg. focusing on its modulation of anxiolytic activity in modulating anxiolytic activity via GABAergic and serotonergic neurotransmission in an adult zebrafish model. The acute toxicity of the chalcone was assessed during a 96-hour period, and the anxiolytic behavior of fish treated with chalcone was evaluated using light/dark tests and open field tests (n=6 animals per group). Chalcone showed no signs of toxicity for up to 96 hours of analysis. The results demonstrated a significant anxiolytic effect of the synthesized chalcone, suggesting its therapeutic potential in treating anxiety. Furthermore, the findings indicate that this anxiolytic effect is mediated by serotonergic and non-GABAergic neurotransmitter systems. From molecular docking simulations, it was possible to estimate that the 5-HT3A receptor (5-HT3AR) pathway is the most likely target way for the chalcone to act. MPO-based ADME predictions indicate that the chalcone exhibits high cellular permeability suggest that chalcone has a high cellular permeability and can distribute better in biological tissues than in blood plasma, supporting its potential to act in the CNS by crossing the blood-brain barrier. These findings enhance the understanding of contribute to understanding of chalcone's mechanisms of action and provide a solid basis for future studies aimed at developing new therapeutic strategies to develop new therapeutic approaches for anxiety disorders.
References
Giacobbe P, Flint A. Diagnosis and Management of Anxiety Disorders. CONTINUUM Lifelong Learning in Neurology 2018; 24: 893-919.
Marder M. Flavonoids as GABAA receptor ligands: the whole story? Journal of Experimental Pharmacology 2012: 9.
Celada P, Bortolozzi A, Artigas F. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: Rationale and current status of research. CNS Drugs 2013; 27: 703-16.
Bandelow B, Michaelis S, Wedekind D. Treatment of Anxiety Disorders. Dialogues in Clinical Neuroscience 2017; 19: 211-37.
Ferreira MKA, da Silva AW, dos Santos Moura AL, Sales KVB, Marinho EM, do Nascimento Martins Cardoso J, et al. Chalcones reverse the anxiety and convulsive behavior of adult zebrafish. Epilepsy and Behavior 2021; 117: 107881.
Buxeraud J, Faure S. Benzodiazepines. Actualites Pharmaceutiques 2019.
Riggs DS. Treatment of Anxiety Disorders. Living and Surviving in Harm’s Way: A Psychological Treatment Handbook for Pre- and Post-Deployment of Military Personnel 2009: 211-37.
Salehi B, Quispe C, Chamkhi I, El Omari N, Balahbib A, Sharifi-Rad J, et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Frontiers in Pharmacology 2021; 11.
Rojas J, Domínguez JN, Charris JE, Lobo G, Payá M, Ferrándiz ML. Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase. European Journal of Medicinal Chemistry 2002; 37: 699-705.
De Campos-Buzzi F, Padaratz P, Meira AV, Corrêa R, Nunes RJ, Cechinel-Filho V. 4′-Acetamidochalcone derivatives as potential antinociceptive agents. Molecules 2007; 12: 896-906.
Higgs J, Wasowski C, Marcos A, Jukič M, Paván CH, Gobec S, et al. Chalcone derivatives: synthesis, in vitro and in vivo evaluation of their anti-anxiety, anti-depression and analgesic effects. Heliyon 2019; 5.
Mendes FR da S, Wlisses da Silva A, Amâncio Ferreira MK, de Lima Rebouças E, Marinho EM, Marinho MM, et al. GABAA receptor participation in anxiolytic and anticonvulsant effects of (E)-3-(furan-2-yl)-1-(2hydroxy-3,4,6-trimethoxy-phenyl)prop-2-en-1-one in adult zebrafish. Neurochemistry International 2022; 155: 105303.
Ferreira MKA, da Silva AW, Silva FCO, Vieira Neto AE, Campos AR, Alves Rodrigues Santos SA, et al. Anxiolytic-like effect of chalcone N-{4’[(2E)-3-(3-nitrophenyl)-1-(phenyl) prop-2-en-1-one]} acetamide on adult zebrafish (Danio rerio): Involvement of the 5-HT system. Biochemical and Biophysical Research Communications 2020; 526: 505-11.
Resende RR, Soccol CR. Biotecnologia aplicada à saúde: fundamentos e aplicações. 1st ed. Capítulo 1: Zebrafish Como Modelo Para Estudos Comportamentais: 2015.
Maximino C, Marques T, Brito D, Waneza A, Manoel A, Morato S, et al. Measuring anxiety in zebrafish : A critical review. Behavioural Brain Research 2010; 214: 157-71.
Maximino C, Puty B, Benzecry R, Araújo J, Lima MG, De Jesus Oliveira Batista E, et al. Role of serotonin in zebrafish (Danio rerio) anxiety: Relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models. Neuropharmacology 2013; 71: 83-97.
Herculano AM, Maximino C. Serotonergic modulation of zebrafish behavior: Towards a paradox. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2014; 55.
Nuss P. Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatric Disease and Treatment 2015; 11: 165-75.
Da Silva PT, Lopes LMA, Xavier JDC, De Carvalho MCS, De Moraes MO, Pessoa C, et al. Cytotoxic and antifungal activity of chalcones synthesized from natural acetophenone isolated from Croton anisodontus. Revista Virtual de Quimica 2020; 12: 712-23.
Amali MO, Atunwa SA, Aiyelero OM, Omotesho QA. Assessment of anxiolytic potential and acute toxicity study of combretum micranthum g. don. leaves (combretaceae) in mice. IBRO Reports 2019; 7: 42.
Arellano-Aguilar O, Solis-Angeles S, Serrano-García L, Morales-Sierra, E. Mendez-Serrano, A. Montero-Montoya R. Use of the Zebrafish Embryo Toxicity Test for Risk Assessment Purpose: Case Study. vol. 9. 2015.
Ahmad F, Richardson MK. Exploratory behaviour in the open field test adapted for larval zebrafish: Impact of environmental complexity. Behavioural Processes 2013; 92: 88-98.
Gonçalves NGG, de Araújo JIF, Magalhães FEA, Mendes FRS, Lobo MDP, Moreira AC de OM, et al. Protein fraction from Artocarpus altilis pulp exhibits antioxidant properties and reverses anxiety behavior in adult zebrafish via the serotoninergic system. Journal of Functional Foods 2020; 66: 103772.
Gebauer DL, Pagnussat N, Piato ÂL, Schaefer IC, Bonan CD, Lara DR. Effects of anxiolytics in zebrafish: Similarities and differences between benzodiazepines, buspirone and ethanol. Pharmacology Biochemistry and Behavior 2011; 99: 480-6.
Benneh CK, Biney RP, Mante, Kolibea P, Tandoh A, Donatus W, Woode E. Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebra fi sh — Involvement of GABAergic and 5-HT systems. Journal of Ethnopharmacology 2017; 207: 129-45.
da Silva AW, Ferreira MKA, Rebouças EL, Mendes FRS, Atilano AL, de Menezes JESA, et al. Anxiolytic-like effect of natural product 2-hydroxy-3,4,6-trimethoxyacetophenone isolated from Croton anisodontus in adult zebrafish via serotonergic neuromodulation involvement of the 5-HT system. Naunyn-Schmiedeberg’s Archives of Pharmacology 2021.
Cosacak MI, Bhattarai P, Bocova L, Dzewas T, Mashkaryan V, Papadimitriou C, et al. Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain. Scientific Reports 2017; 7: 1-14.
Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff A V. Zebrafish models for translational neuroscience research: From tank to bedside. Trends in Neurosciences 2014; 37: 264-78.
Bugel SM, Tanguay RL. Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish. Toxicology and Applied Pharmacology 2018; 344: 23-34.
Gupta P, Khobragade S, Rajaram S, Shingatgeri V. Assessment of locomotion behavior in adult Zebrafish after acute exposure to different pharmacological reference compounds. Drug Development and Therapeutics 2014; 5: 127.
Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff A V. Modeling anxiety using adult zebrafish: A conceptual review. Neuropharmacology 2012; 62: 135-43.
Cachat J, Stewart A, Utterback E, Hart P, Gaikwad S, Wong K, et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 2011; 6.
Mrinalini R, Tamilanban T, Kumar VN, Manasa K. Zebrafish – The Neurobehavioural Model in Trend. Neuroscience 2022.
de Abreu MS, Giacomini ACVV, Genario R, dos Santos BE, da Rosa LG, Demin KA, et al. Neuropharmacology, pharmacogenetics and pharmacogenomics of aggression: The zebrafish model. Pharmacological Research 2019; 141: 602-8.
Stewart A, Wu N, Cachat J, Hart P, Gaikwad S, Wong K, et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011; 35: 1421-31.
Maximino C, de Brito TM, Colmanetti R, Pontes AAA, de Castro HM, de Lacerda RIT, et al. Parametric analyses of anxiety in zebrafish scototaxis. Behavioural Brain Research 2010; 210: 1-7.
Bhathiwal AS, Bendi A, Tiwari A. A study on synthesis of benzodiazepine scaffolds using biologically active chalcones as precursors. Journal of Molecular Structure 2022; 1258: 132649.
Silva Mendes FR, Wlisses da Silva A, Amâncio Ferreira MK, de Lima Rebouças E, Marinho EM, Marinho MM, et al. GABAA receptor participation in anxiolytic and anticonvulsant effects of (E)-3-(furan-2-yl)-1-(2hydroxy-3,4,6-trimethoxy-phenyl)prop-2-en-1-one in adult zebrafish. Neurochemistry International 2022; 155.
Ferreira MKA, da Silva AW, Silva FCO, Vieira Neto AE, Campos AR, Alves Rodrigues Santos SA, et al. Anxiolytic-like effect of chalcone N-{4’[(2E)-3-(3-nitrophenyl)-1-(phenyl)prop-2-en-1-one]} acetamide on adult zebrafish (Danio rerio): Involvement of the 5-HT system. Biochemical and Biophysical Research Communications 2020; 526.
Nowicki M, Tran S, Muraleetharan A, Markovic S, Gerlai R. Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner. Pharmacology Biochemistry and Behavior 2014; 126: 170-80.
Lillesaar C, Gaspar P. Serotonergic neurons in vertebrate and invertebrate model organisms (Rodents, zebrafish, drosophila melanogaster, aplysia californica, caenorhabditis elegans). Elsevier Inc.; 2018.
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.